Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hyperphagia × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Other hematologic neoplasm 2 Other 1 Genitourinary 1

Conditions

Obesity 365 Neoplasms 138 Mucositis 112 Breast Neoplasms 98 Sexual Dysfunction, Physiological 91 Overweight 87 Polycystic Ovary Syndrome 86 Dyspnea 57 Constipation 51 Motor Activity 48 Head and Neck Neoplasms 42 Prostatic Neoplasms 38 Weight Loss 34 Diabetes Mellitus 31 Colorectal Neoplasms 30 Pain 28 Opioid-Induced Constipation 28 Stomatitis 25 Lung Neoplasms 25 Endometrial Neoplasms 24 Depression 24 Diabetes Mellitus, Type 2 22 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Obesity, Morbid 19 Multiple Endocrine Neoplasia Type 1 19 Insulin Resistance 19 Cardiovascular Diseases 19 Anxiety Disorders 19 Sexual Dysfunctions, Psychological 16 Metabolic Syndrome 16

Interventions

fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡